IT1298918B1 - Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche - Google Patents

Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche

Info

Publication number
IT1298918B1
IT1298918B1 IT98RM000103A ITRM980103A IT1298918B1 IT 1298918 B1 IT1298918 B1 IT 1298918B1 IT 98RM000103 A IT98RM000103 A IT 98RM000103A IT RM980103 A ITRM980103 A IT RM980103A IT 1298918 B1 IT1298918 B1 IT 1298918B1
Authority
IT
Italy
Prior art keywords
bacteria
reduce
pharmaceutical compositions
induce apoptosis
inflammatory reaction
Prior art date
Application number
IT98RM000103A
Other languages
English (en)
Italian (it)
Inventor
Simone Claudio De
Original Assignee
Mendes Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes Srl filed Critical Mendes Srl
Publication of ITRM980103A0 publication Critical patent/ITRM980103A0/it
Priority to IT98RM000103A priority Critical patent/IT1298918B1/it
Priority to KR20007008973A priority patent/KR100594569B1/ko
Priority to ES98950301T priority patent/ES2303357T3/es
Priority to PCT/IT1998/000275 priority patent/WO1999042568A1/en
Priority to PT98950301T priority patent/PT1058725E/pt
Priority to US09/601,533 priority patent/US6572854B1/en
Priority to BR9815677-2A priority patent/BR9815677A/pt
Priority to TR2000/02326T priority patent/TR200002326T2/xx
Priority to AU96441/98A priority patent/AU754483B2/en
Priority to JP2000532508A priority patent/JP4253439B2/ja
Priority to CA002321263A priority patent/CA2321263C/en
Priority to HK01104084.8A priority patent/HK1033338B/xx
Priority to IL13779998A priority patent/IL137799A/xx
Priority to AT98950301T priority patent/ATE391774T1/de
Priority to CNB988137054A priority patent/CN1189560C/zh
Priority to EA200000856A priority patent/EA006018B1/ru
Priority to DE69839351T priority patent/DE69839351T2/de
Priority to SI9830908T priority patent/SI1058725T1/sl
Priority to EP98950301A priority patent/EP1058725B1/en
Priority to DK98950301T priority patent/DK1058725T3/da
Priority to ZA9811619A priority patent/ZA9811619B/xx
Priority to ARP990100064A priority patent/AR020053A1/es
Priority to IN117CA1999 priority patent/IN188450B/en
Priority to IN116KO1999 priority patent/IN1999KO00116A/en
Publication of ITRM980103A1 publication Critical patent/ITRM980103A1/it
Application granted granted Critical
Publication of IT1298918B1 publication Critical patent/IT1298918B1/it
Priority to MXPA00007990 priority patent/MX237377B/es
Priority to US10/400,675 priority patent/US7147847B2/en
Priority to CY20081100582T priority patent/CY1108112T1/el
Priority to ARP090101791A priority patent/AR071841A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT98RM000103A 1998-02-20 1998-02-20 Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche IT1298918B1 (it)

Priority Applications (28)

Application Number Priority Date Filing Date Title
IT98RM000103A IT1298918B1 (it) 1998-02-20 1998-02-20 Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
CNB988137054A CN1189560C (zh) 1998-02-20 1998-10-13 具有精氨酸脱亚氨酶的细菌的用途以及含有该细菌的组合物
EA200000856A EA006018B1 (ru) 1998-02-20 1998-10-13 Штамм молочно-кислых бактерий laktobacillus brevis cd2 dsm11988, синтезирующий аргининдезиминазу, и применение указанного штамма и других бактерий, синтезирующих данный фермент, для индукции апоптоза и/или уменьшения воспалительной реакции, и фармацевтическая композиция, содержащая такие бактерии
PCT/IT1998/000275 WO1999042568A1 (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
PT98950301T PT1058725E (pt) 1998-02-20 1998-10-13 Utilização de bactérias dotadas com desiminase de arginina, para induzir apoptose e/ou reduzir uma reacção inflamatória e composições dietéticas ou farmacêuticas contendo essas bactérias
US09/601,533 US6572854B1 (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
BR9815677-2A BR9815677A (pt) 1998-02-20 1998-10-13 Uso de bactérias dotadas de arginina deiminase para indução de apoptose e/ou redução de uma reação inflamatória e composições farmacêuticas ou dietéticas contendo tais bactérias
TR2000/02326T TR200002326T2 (tr) 1998-02-20 1998-10-13 Bir apoptoz meydana getirmek ve/veya iltihapsal reaksiyonu azaltmak için arjinin deiminaz ile donatılmış bakteri kullanımı ve bu tür bakterileri içeren ilaç veya besin karışımları
AU96441/98A AU754483B2 (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
JP2000532508A JP4253439B2 (ja) 1998-02-20 1998-10-13 アポトーシスを誘発しおよび／または炎症反応を低下するためのアルギニン・デイミナーゼに富む細菌の使用、および該細菌を含有する医薬組成物または健康食組成物
CA002321263A CA2321263C (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
HK01104084.8A HK1033338B (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
IL13779998A IL137799A (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
AT98950301T ATE391774T1 (de) 1998-02-20 1998-10-13 Verwendung von bakterien mit arginin- deiminaseaktivität zur induktion der apoptose und/oder zur hemmung einer entzündungsreaktion, und diese enthaltende pharmazeutische oder diätetische zusammensetzungen
KR20007008973A KR100594569B1 (ko) 1998-02-20 1998-10-13 아폽토시스를 유도 및/또는 염증반응을 감소시키는 아르기닌 데이미나제를 함유하는 박테리아의 용도 및 그러한 박테리아를 포함하는 약제학적 또는 식이성 조성물
DE69839351T DE69839351T2 (de) 1998-02-20 1998-10-13 Verwendung von bakterien mit arginin-deiminaseaktivität zur induktion der apoptose und/oder zur hemmung einer entzündungsreaktion, und diese enthaltende pharmazeutische oder diätetische zusammensetzungen
SI9830908T SI1058725T1 (sl) 1998-02-20 1998-10-13 Uporaba bakterije obogatene z argininsko deiminazo za nastanek apoptoze in/ali zmanjšanje vnetne reakcije, ter farmacevtske ali dietetične zmesi, ki vsebujejo takšne bakterije
ES98950301T ES2303357T3 (es) 1998-02-20 1998-10-13 Uso de una bacteria dotada de arginina deimanasa para inducir apoptosis y/o reducir una reaccion inflamatoria, y composiciones farmaceuticas o dieteticas que contienen dicha bacteria.
EP98950301A EP1058725B1 (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
DK98950301T DK1058725T3 (da) 1998-02-20 1998-10-13 Anvendelse af bakterier, som indeholder arginindeiminase, til induktion af apoptose og/eller reduktion af en inflammatorisk reaktion og farmaceutiske eller diætetiske præparater, der indholder sådanne bakterier
ZA9811619A ZA9811619B (en) 1998-02-20 1998-12-18 Uses of bacteria endowed with arginine deiminase and compositions containing such bacteria
ARP990100064A AR020053A1 (es) 1998-02-20 1999-01-08 Una composicion farmaceutica, dietetica o nutricional y su uso.
IN116KO1999 IN1999KO00116A (en:Method) 1998-02-20 1999-02-15
IN117CA1999 IN188450B (en:Method) 1998-02-20 1999-02-15
MXPA00007990 MX237377B (es) 1998-02-20 2000-08-16 Composiciones para inducir apoptosis y/o reducir reaccion inflamatoria que comprenden una bacteria lactica productora de arginina desaminasa
US10/400,675 US7147847B2 (en) 1998-02-20 2003-03-28 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
CY20081100582T CY1108112T1 (el) 1998-02-20 2008-06-03 Χρηση βακτηριδιων προικισμενων με αποïμιναση αργινινης για να διεγειρεται αποπτωση ή/και να μειωνεται μια φλεγμοnωδης αντιδραση και φαρμακευτικες ή διαιτητικες συνθεσεις που περιεχουν τετοια βακτηριδια
ARP090101791A AR071841A2 (es) 1998-02-20 2009-05-19 Cepa de bacterias lacticas dotadas de actividad de diseminasa de arginina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000103A IT1298918B1 (it) 1998-02-20 1998-02-20 Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
ITRM980103A0 ITRM980103A0 (it) 1998-02-20
ITRM980103A1 ITRM980103A1 (it) 1999-08-20
IT1298918B1 true IT1298918B1 (it) 2000-02-07

Family

ID=11405583

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98RM000103A IT1298918B1 (it) 1998-02-20 1998-02-20 Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche

Country Status (24)

Country Link
US (2) US6572854B1 (en:Method)
EP (1) EP1058725B1 (en:Method)
JP (1) JP4253439B2 (en:Method)
KR (1) KR100594569B1 (en:Method)
CN (1) CN1189560C (en:Method)
AR (2) AR020053A1 (en:Method)
AT (1) ATE391774T1 (en:Method)
AU (1) AU754483B2 (en:Method)
BR (1) BR9815677A (en:Method)
CA (1) CA2321263C (en:Method)
CY (1) CY1108112T1 (en:Method)
DE (1) DE69839351T2 (en:Method)
DK (1) DK1058725T3 (en:Method)
EA (1) EA006018B1 (en:Method)
ES (1) ES2303357T3 (en:Method)
IL (1) IL137799A (en:Method)
IN (2) IN188450B (en:Method)
IT (1) IT1298918B1 (en:Method)
MX (1) MX237377B (en:Method)
PT (1) PT1058725E (en:Method)
SI (1) SI1058725T1 (en:Method)
TR (1) TR200002326T2 (en:Method)
WO (1) WO1999042568A1 (en:Method)
ZA (1) ZA9811619B (en:Method)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
HU227086B1 (en) 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
MXPA04001999A (es) * 2001-09-05 2004-07-16 Vsl Pharmaceuticals Inc Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
CN1809378B (zh) * 2002-11-18 2010-06-23 德西涅Rx制药公司 体内抑制病毒复制的方法
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
CA2609617C (en) 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
CA2673235A1 (en) 2006-12-21 2008-06-26 Calpis Co., Ltd. Agents for promoting iga production
CN100584940C (zh) * 2007-05-17 2010-01-27 江南大学 一株产精氨酸脱亚氨酶的菌种及其应用
JP5247120B2 (ja) * 2007-11-02 2013-07-24 雪印メグミルク株式会社 Ｌ−オルニチン含有物の製造方法
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
JP5526320B2 (ja) * 2008-09-04 2014-06-18 国立大学法人旭川医科大学 腸管保護剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN106890198A (zh) * 2009-10-22 2017-06-27 株式会社益力多本社 癌症发病风险降低剂
JP5660508B2 (ja) * 2010-04-08 2015-01-28 国立大学法人旭川医科大学 腸管保護剤
KR101062779B1 (ko) 2010-04-28 2011-09-06 삼육대학교산학협력단 충치 유발 세균의 성장 억제 활성을 나타내는 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 또는 이의 배양물을 유효 성분으로 하는 충치 예방용 식품 및 약제학 조성물
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN102433290B (zh) * 2012-01-16 2013-06-12 江南大学 一株产瓜氨酸的菌株及用该菌株生物合成瓜氨酸的方法
JP2014521602A (ja) 2012-04-04 2014-08-28 ポラリス グループ アルギニンデイミナーゼを用いる処置方法
JP6382934B2 (ja) 2013-03-15 2018-08-29 ポラリス グループ 癌治療のためのａｄｉ−ｐｅｇ２０抗体に対して低減された交差反応性を有するアルギニンデイミナーゼ
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
JP6535285B2 (ja) * 2014-01-22 2019-06-26 株式会社明治 シトルリンの調製方法
SG11201607736UA (en) 2014-03-18 2016-10-28 Tdw Group Engineered chimeric pegylated adi and methods of use
TWI775160B (zh) 2014-09-16 2022-08-21 開曼群島商瑞華藥業集團 用於治療癌症之與adi-peg 20抗體具有降低之交叉反應性的精胺酸脫亞胺酶
SG10201913609PA (en) 2014-12-23 2020-03-30 4D Pharma Res Ltd Immune modulation
SMT201800291T1 (it) 2014-12-23 2018-07-17 4D Pharma Res Limited Polipeptide pirina e modulazione immunitaria
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
SMT201900539T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
EP3360559B1 (en) 2015-06-15 2019-10-23 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CA3005781C (en) 2015-11-20 2019-01-22 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN106994134B (zh) * 2016-01-25 2020-08-25 深圳华大生命科学研究院 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
CA3016179C (en) 2016-03-04 2019-08-13 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
WO2018009528A1 (en) 2016-07-05 2018-01-11 Tdw Group Combination cancer immunotherapies with arginine depletion agents
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
CN110121340B (zh) 2016-11-02 2023-03-31 波拉里集团 聚乙二醇化精氨酸脱亚氨酶的调配物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018125735A1 (en) * 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
CN108265068B (zh) * 2016-12-31 2021-06-15 江苏众红生物工程创药研究院有限公司 重组精氨酸脱亚胺酶及其产业化制备方法和应用
TW201907929A (zh) 2017-05-22 2019-03-01 英商4D製藥研究有限公司 包含細菌品系之組成物
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
LT3638271T (lt) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozicijos, apimančios bakterines padermes
PL3600363T3 (pl) 2017-06-14 2021-06-14 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
WO2018229236A2 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
FR3082207B1 (fr) * 2018-06-06 2022-03-25 Agronomique Inst Nat Rech Nouvelle souche probiotique de lactobacillus brevis
KR102069622B1 (ko) * 2019-06-25 2020-01-23 한국식품연구원 락토바실러스 퍼멘텀 WiKim0102를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
US20230113992A1 (en) * 2020-04-17 2023-04-13 Claudio De Simone Use of bacterial compositions in the treatment and prophylaxis of airway diseases
CN115916230A (zh) * 2020-06-22 2023-04-04 株式会社明治 用于促进白细胞介素-10产生的组合物
KR102363111B1 (ko) * 2021-06-29 2022-02-15 (주)바이오일레븐 항염 및 항산화 활성을 갖는 락토바실러스 퍼멘텀 균주 및 이의 용도
KR102822265B1 (ko) * 2023-02-27 2025-06-19 퓨리셀매니아 주식회사 신규 락토바실러스 브리비스 균주 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415550A (en) * 1983-03-04 1983-11-15 Pakhomov Gennady N Treatment-and-prophylactic tooth paste possessing anticarious effect
JP2900279B2 (ja) * 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
US5196195A (en) * 1990-03-27 1993-03-23 Cornell Research Foundation, Inc. Use of arginase to control nitric oxide formation
GB9107305D0 (en) * 1991-04-08 1991-05-22 Unilever Plc Probiotic
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders
US5599795A (en) * 1994-08-19 1997-02-04 Mccann; Michael Method for treatment of idiopathic inflammatory bowel disease (IIBD)

Also Published As

Publication number Publication date
KR20010106092A (ko) 2001-11-29
EP1058725A1 (en) 2000-12-13
DE69839351D1 (de) 2008-05-21
AU9644198A (en) 1999-09-06
JP4253439B2 (ja) 2009-04-15
JP2002504324A (ja) 2002-02-12
ES2303357T3 (es) 2008-08-01
AR020053A1 (es) 2002-04-10
TR200002326T2 (tr) 2000-11-21
EA006018B1 (ru) 2005-08-25
IL137799A (en) 2005-08-31
IN1999KO00116A (en:Method) 2005-03-11
AU754483B2 (en) 2002-11-14
US20030215429A1 (en) 2003-11-20
ATE391774T1 (de) 2008-04-15
HK1033338A1 (en) 2001-08-24
DK1058725T3 (da) 2008-08-18
CY1108112T1 (el) 2014-02-12
CN1189560C (zh) 2005-02-16
CA2321263A1 (en) 1999-08-26
CA2321263C (en) 2009-08-11
US6572854B1 (en) 2003-06-03
KR100594569B1 (ko) 2006-06-30
MXPA00007990A (es) 2001-03-01
WO1999042568A1 (en) 1999-08-26
EP1058725B1 (en) 2008-04-09
ITRM980103A0 (it) 1998-02-20
ITRM980103A1 (it) 1999-08-20
CN1284994A (zh) 2001-02-21
IL137799A0 (en) 2001-10-31
ZA9811619B (en) 1999-06-23
AR071841A2 (es) 2010-07-21
US7147847B2 (en) 2006-12-12
SI1058725T1 (sl) 2008-08-31
DE69839351T2 (de) 2009-06-25
EA200000856A1 (ru) 2001-02-26
MX237377B (es) 2006-05-31
BR9815677A (pt) 2000-10-24
PT1058725E (pt) 2008-06-19
IN188450B (en:Method) 2002-09-28

Similar Documents

Publication Publication Date Title
IT1298918B1 (it) Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
ID28113A (id) Komposisi zat tepung leleh yang dapat diproses
EE200100659A (et) Diaminotiasoolid ja nende kasutamine proteiinikinaaside pärssimiseks
NO20014409D0 (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
CY2006003I2 (el) Χρηση δαπτομυκινης
NO20014858L (no) Anvendelse av CYP2D6 inhibitorer i kombinasjonsterapi
IS6254A (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
PT1066027E (pt) Composicao farmaceutica de topiramato
AU2002352443A1 (en) Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3
HUP0201214A3 (en) Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use
NO20015112L (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
MA26818A1 (fr) Formulations contenant des inhibiteurs de lipase
DE59910836D1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
EP1572084A4 (en) MAMMALS WITH PARTICIPATION IN VIRUS INFECTION AND TUMORSUPPRESSION
IT1293508B1 (it) Associazione di filtri solari e composizioni che le contengono
AU2002354951A1 (en) Use of copper chelators to inhibit the inactivation of protein c
EP1082127A4 (en) INTERLEUKIN CONVERSION ENZYME INHIBITORS $ 1 g (b)
BR0012675A (pt) Uso de inibidores de il-18
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
DE60118910D1 (de) Phosphatkonversionsüberzugverfahren und zusammensetzung
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
AU7104500A (en) Use of rafp to inhibit or prevent apoptosis
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
IT1319128B1 (it) Procedimento e dispositivo per prelevare tipo di conducente

Legal Events

Date Code Title Description
0001 Granted